Status:
COMPLETED
Randomized Controlled Trial of Gemcitabine Combined With 125I Brachytherapy
Lead Sponsor:
Huazhong University of Science and Technology
Conditions:
Locally Advanced Pancreatic Cancer
Eligibility:
All Genders
18-75 years
Phase:
PHASE3
Brief Summary
For patients with unresectable locally advanced pancreatic cancer, the combined use of external-beam radiation therapy (EBRT) and systemic chemotherapy of 5-FU has been widely recognized as the most e...
Eligibility Criteria
Inclusion
- Histologically proven
- locally advanced pancreatic adenocarcinoma stage
- No systemic metastases
- Age between 18-75
- Karnofsky-Performance Status equal to, or greater than 70 %
- At least a 2-dimensionally measurable tumor lesion
- Adequate renal and liver function
- Written consent statement
- Patients' compliance and geographical proximity
- Life expectancy equal to or greater than 3 months
Exclusion
- Serious psychological disease
- Pregnancy and inadequate or not secure contraception or breastfeeding women
- Other previous malignant disease in the past two years
- Serious systemic concomitant diseases, excluding participation in a trial
- Other experimental treatment during or within 6 weeks prior to this trial (including chemotherapeutic medicine or immune-therapies)
- Every other condition or therapy assessed by the physician as an eventual risk for the patient or restricting the aims of the trial
- Distant metastasis
Key Trial Info
Start Date :
January 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2008
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT00644618
Start Date
January 1 2003
End Date
January 1 2008
Last Update
March 27 2008
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.